J&J launches Asia Pacific Innovation Center

Johnson & Johnson (J&J) Innovation has expanded its global network of research partnering hubs with the opening of the Asia Pacific Innovation Center headquartered in Shanghai

The Center extends the network of J&J Innovation Centers in lifesciences hotspots around the globe

Bangalore:

Johnson & Johnson (J&J) Innovation has announced the opening of the Asia Pacific Innovation Center, located in Shanghai with satellites in Singapore, Australia and Japan. It extend network of J&J Innovation Centers in lifesciences hotspots around the globe. With local science and technology experts and deal-making capabilities, the center will identify and develop promising early-stage opportunities across the company's areas of focus pharmaceuticals, medical devices and diagnostics, and consumer healthcare products.

"We are excited to launch the Asia Pacific Innovation Center which builds on the momentum of our Centers in London, California and Boston. Our goal is to collaborate with the best minds in the region to advance new technologies and deliver transformative solutions for the people of China and Asia Pacific at large, and throughout the world," said Mr Paul Stoffels, J&J's chief scientific officer and worldwide chairman, pharmaceuticals.

Mr Dong Wu, Head of the J&J Innovation Asia Pacific Innovation Center, said, "There is an explosion of growth in the Asia Pacific region, and China in particular, as well as significant medical needs. The Asia Pacific Innovation Center plans to build on the Company's track record of collaboration in the region and advance the most promising science. It will play a key role in sourcing early stage science in the region for the development of new medicines, medical devices, and consumer products."

J&J Innovation is working with key stakeholders in China including the government, industry and academic partners to accelerate innovation for China and around the world. Through the Innovation Center, regionally-based entrepreneurs and scientists in Asia Pacific have one-stop access to customised support for promising early-stage ideas and technologies including funding, early and commercial expertise.

"The J&J Family of Companies has a long standing presence in China extending back almost 30 years. Our on the ground presence across the region allows us to work side by side with our partners with speed, agility, and insight to translate innovations into new products. The Asia Pacific Innovation Center supports our larger goal to address China's specific healthcare needs, invest in local capabilities, and increase our external collaborations," commented Mr Jesse Wu, chairman, J&J, China.